Panel Discussion | Can We and Should We Skip TEE for LAA Closure? Role of CT and ICE?

Saturday, March 8, 2025

12:02 PM – 12:20 PM ET

Moderator(s)

Creighton W. Don, MD

Professor of Medicine/Cardiology Director of the Interventional Cardiology and Structural Heart Fellowships
University of Washington
Seattle, Washington, United States

Disclosure(s): No financial relationships to disclose
Antonio Frangieh, MD

Medical Director Structural Heart Program, Associate Professor of Medicine
University Of California Irvine
Orange, California, United States

Disclosure(s): Edward Lifesciences: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Jacqueline Saw, MD

Clinical Professor
University of British Columbia, British Columbia, Canada

Disclosure information not submitted.

Panel Discussant(s)

Stewart M. Benton, Jr., MD

Interventional Cardiologist
WellSpan Health
York, Pennsylvania, United States

Disclosure information not submitted.
Scott M. Chadderdon, MD

Associate Professor
OHSU
PORTLAND, Oregon, United States

Disclosure(s): Edward Lifesciences: Consultant (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing)
Tarun Chakravarty, MD

Associate Professor, Interventional Cardiology
Cedars-Sinai Medical Center
Los Angeles, California, United States

Disclosure(s): Cedars-Sinai Medical Center: Employee (Ongoing); Edwards Lifesciences: Consultant (Ongoing)
Chetan Huded, MD, MSc

Associate Medical Director, Structural Intervention
Saint Luke's Mid America Heart Institute
Kansas City, Missouri, United States

Disclosure(s): Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Terminated)
Uzoma N. Ibebuogu, MD

Professor of Medicine
University of Tennessee
Memphis , Tennessee, United States

Disclosure(s): No financial relationships to disclose
Nabil Dib, MD, MSc, FACC, FESC

Director Cardiovascular Research
Mercy Gilbert Medical Center/Dignity Health
Gilbert, Arizona, United States

Disclosure(s): Dib UltraNav Medical, LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Creighton W. Don, MD

Professor of Medicine/Cardiology Director of the Interventional Cardiology and Structural Heart Fellowships
University of Washington
Seattle, Washington, United States

Disclosure(s): No financial relationships to disclose
Sunil V. Mankad, MD

Director, Transesophageal Echocardiography
Mayo Clinic
Rochester, Minnesota, United States

Disclosure(s): No financial relationships to disclose
Tilak K. R Pasala, MD

Medical Director of Structural Heart Disease
The Cardiovascular Center of Florida
Orlando, Florida, United States

Disclosure(s): No financial relationships to disclose
Gagan D. Singh, MD

Clinical Professor
University of California Davis Health
Sacramento, California, United States

Disclosure(s): Boston Scientific Corporation: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Phillips: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Creighton W. Don, MD: No financial relationships to disclose

Antonio Frangieh, MD: Edward Lifesciences: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Scott M. Chadderdon, MD: Edward Lifesciences: Consultant (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing)

Tarun Chakravarty, MD: Cedars-Sinai Medical Center: Employee (Ongoing); Edwards Lifesciences: Consultant (Ongoing)

Chetan Huded, MD, MSc: Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Terminated)

Nabil Dib, MD, MSc, FACC, FESC: Dib UltraNav Medical, LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Sunil V. Mankad, MD: No financial relationships to disclose

Tilak K. R Pasala, MD: No financial relationships to disclose

Gagan D. Singh, MD: Boston Scientific Corporation: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Phillips: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)